Advertisement
New Zealand markets closed
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NZD/USD

    0.5977
    -0.0029 (-0.48%)
     
  • NZD/EUR

    0.5538
    -0.0005 (-0.09%)
     
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • OIL

    83.07
    +1.72 (+2.11%)
     
  • GOLD

    2,240.20
    +27.50 (+1.24%)
     
  • NASDAQ

    18,269.43
    -11.41 (-0.06%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,805.34
    +45.26 (+0.11%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • NZD/JPY

    90.4270
    -0.3530 (-0.39%)
     

Jazz: 2Q Earnings Snapshot

Jazz: 2Q Earnings Snapshot

DUBLIN (AP) _ Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported second-quarter profit of $92.3 million.

On a per-share basis, the Dublin-based company said it had net income of $1.50. Earnings, adjusted for one-time gains and costs, were $3.49 per share.

The results exceeded Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $3.22 per share.

The drugmaker posted revenue of $500.5 million in the period, also topping Street forecasts. Ten analysts surveyed by Zacks expected $469.8 million.

Jazz expects full-year earnings in the range of $12.75 to $13.25 per share, with revenue in the range of $1.88 billion to $1.93 billion.

ADVERTISEMENT

Jazz shares have increased 34 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $179.90, an increase of 16 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ